S32 is a venture capital firm investing at the frontiers of technology. Founded by Bill Maris, the team has vast experience building iconic companies. Our goal is to accelerate the discovery, development, and distribution of revolutionary technologies that improve the human condition. We invest across the entirety of technology. This includes artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology. Follow us on Twitter: https://twitter.com/S32_VC
Location: United States, California, Palo Alto
Employees: 11-50
Founded date: 2017
Investment Type: Venture Capital
Portfolio 92
| Date | Name | Website | Total Raised | Location |
| - | Metaphysic... | metaphysic.ai | - | United Kin... |
| - | ROME Thera... | rometx.com | $50M | United Sta... |
| - | Primer | primer.ai | $219M | - |
| - | Inworld AI | inworld.ai | $577M | United Sta... |
| - | GeneDx | genedx.com | - | United Sta... |
| - | Nusano | nusano.com | $115M | United Sta... |
| - | Lime | li.me | $1.39B | United Sta... |
| - | Coinbase W... | coinbase.com | $555.17M | United Sta... |
| - | Kestrel Th... | kestreltherapeutics.com | $40M | United Sta... |
| - | Wise Syste... | wisesystems.com | $122M | United Sta... |
Show more
Mentions in press and media 7
| Date | Title | Description |
| 22.10.2024 | Sunbird Bio: $14 Million Closed To Advance Blood-Based Diagnostic Platform In Alzheimer’s Disease | Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve the diagnosis and treatment of neurological disorders and early-stage cancer, announced the closing of a $14 million financing round backed by t... |
| 26.03.2024 | Brightside Health Secures $33M to Expand Access to Mental Healthcare | What You Should Know: – Brightside Health, a teletherapy provider for depression, anxiety, and other mood disorders, raises $33M in Series C funding led by S32. – The funding round, which included participation from existing investors along... |
| 13.03.2024 | IVF uncertainty aside, startups rush to offer fertility care amid rising demand | AI tools, egg freezing, surrogacy, IUI, donorship, oncofertility, genetic analysis, loans, and more In the aftermath of the Roe v. Wade overturn, U.S. fertility clinics (and patients alongside them) are battling an unlikely complication in ... |
| 27.02.2024 | Freenome scores $254M to advance its cancer-detection blood tests | The San Francisco company readies to reveal its first clinical study results in the near term When it comes to cancer, spotting it early can make a big difference on treatment options and survival. Commonly a progressive disease, certain un... |
| 20.02.2024 | Freenome's $254M Boost for Early Cancer Detection | Freenome, a biotech company in San Francisco, just secured a massive $254M in funding to advance their blood-based cancer detection tests. The investment, led by Roche and backed by a slew of other big names, will propel Freenome's mission ... |
| 15.02.2024 | Freenome Raises $254M to Accelerate Early Cancer Detection Platform | What You Should Know: – Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was led by Roche with parti... |
| 06.10.2023 | Section 32 Closes $525M Fund 5 | Section 32, a Palo Alto, CA-based venture capital firm, closed its Fund 5, at $525M. The fund will invest in companies that are pushing the boundaries in software and artificial intelligence (“AI”) to enable new capabilities and step-change... |